BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen Y, Zhou Q, Wang H, Zhuo W, Ding Y, Lu J, Wu G, Xu N, Teng L. Predicting Peritoneal Dissemination of Gastric Cancer in the Era of Precision Medicine: Molecular Characterization and Biomarkers. Cancers (Basel) 2020;12:E2236. [PMID: 32785164 DOI: 10.3390/cancers12082236] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Nagamura Y, Miyazaki M, Nagano Y, Yuki M, Fukami K, Yanagihara K, Sasaki K, Sakai R, Yamaguchi H. PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification. Oncogenesis 2021;10:25. [PMID: 33677467 DOI: 10.1038/s41389-021-00314-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yang Y, He W, Wang ZR, Wang YJ, Li LL, Lu JZ, Tao Y, Zhang J, Fu SJ, Wang ZP, Liu SH. Immune Cell Landscape in Gastric Cancer. Biomed Res Int 2021;2021:1930706. [PMID: 33575321 DOI: 10.1155/2021/1930706] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Xu P, Xu X, Zhang L, Li Z, Qiang J, Yao J, Xu A. hsa_circ_0060975 is highly expressed and predicts a poor prognosis in gastric cancer. Oncol Lett 2021;22:619. [PMID: 34257727 DOI: 10.3892/ol.2021.12880] [Reference Citation Analysis]
4 Nagamura Y, Miyazaki M, Nagano Y, Tomiyama A, Ohki R, Yanagihara K, Sakai R, Yamaguchi H. SHP2 as a Potential Therapeutic Target in Diffuse-Type Gastric Carcinoma Addicted to Receptor Tyrosine Kinase Signaling. Cancers (Basel) 2021;13:4309. [PMID: 34503119 DOI: 10.3390/cancers13174309] [Reference Citation Analysis]
5 Chen Y, Xi W, Yao W, Wang L, Xu Z, Wels M, Yuan F, Yan C, Zhang H. Dual-Energy Computed Tomography-Based Radiomics to Predict Peritoneal Metastasis in Gastric Cancer. Front Oncol 2021;11:659981. [PMID: 34055627 DOI: 10.3389/fonc.2021.659981] [Reference Citation Analysis]
6 Hu XY, Ling ZN, Hong LL, Yu QM, Li P, Ling ZQ. Circulating methylated THBS1 DNAs as a novel marker for predicting peritoneal dissemination in gastric cancer. J Clin Lab Anal 2021;35:e23936. [PMID: 34390026 DOI: 10.1002/jcla.23936] [Reference Citation Analysis]
7 Gęca K, Rawicz-Pruszyński K, Mlak R, Sędłak K, Skórzewska M, Pelc Z, Małecka-Massalska T, Polkowski WP. Molecular Cytology by One-Step Nucleic Acid Amplification (OSNA) Assay of Peritoneal Washings during D2 Gastrectomy in Advanced Gastric Cancer Patients: Preliminary Results. J Clin Med 2021;10:5230. [PMID: 34830512 DOI: 10.3390/jcm10225230] [Reference Citation Analysis]
8 Zou D, Song J, Deng M, Ma Y, Yang C, Liu J, Wang S, Wen Z, Tang Y, Qu X, Zhang Y. Bufalin inhibits peritoneal dissemination of gastric cancer through endothelial nitric oxide synthase-mitogen-activated protein kinases signaling pathway. FASEB J 2021;35:e21601. [PMID: 33913201 DOI: 10.1096/fj.202002780R] [Reference Citation Analysis]
9 Ozawa H, Imazeki H, Ogiwara Y, Kawakubo H, Fukuda K, Kitagawa Y, Kudo-Saito C. Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer. Transl Oncol 2021;16:101307. [PMID: 34902741 DOI: 10.1016/j.tranon.2021.101307] [Reference Citation Analysis]